Alnylam Pharmaceuticals
Price & Volume
Stats
See more52W Range | $273.11-$495.55 |
Market Cap | $39.8B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $4.2B |
Revenue Growth (YoY) | 96.4% |
Gross Profit (12 Mos) | $3.4B |
Diluted EPS | $3.97 |
News
See moreYahoo Finance • 2 days ago
Panic grips Ionis Pharmaceuticals investors amid bad news spree
Yahoo Finance • 4 days ago
Is Rival ATTR-CM Trial Failure and New AI Deals Altering The Investment Case For Alnylam (ALNY)?
Yahoo Finance • 4 days ago
Alnylam (ALNY) Gets An Opening In ATTR CM As Rival Trial Fails
Yahoo Finance • 4 days ago
Alnylam Pharmaceuticals (ALNY) Stock Looks Rich On Earnings Yet Strong On Returns
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,500 |